| SALEM, Joe-Elie |
ACHLYS, NCT05195645: AbataCept for the Treatment of Immune-cHeckpoint Inhibitors Induced mYocarditiS |
|
|
| Active, not recruiting | 2 | 21 | Europe | Abatacept 250 MG, ORENCIA® BMS | Assistance Publique - Hôpitaux de Paris | Myocarditis | 10/24 | 09/25 | | |
CARDIOSTEM, NCT05594433: Donation of Whole Blood by Healthy Volunteers After Mobilisation by Haematopoietic Growth Factor (Rhu-G-CSF = Granocyte) |
|
|
| Recruiting | 1 | 40 | Europe | Lenograstim, Granocyte(R) | CellProthera | Healthy Volunteers | 12/24 | 01/25 | | |
| Completed | N/A | 120 | Europe | ECG, blood test (assessing ionic and hormonal circulating levels) | University Hospital, Bordeaux, APHP | Transgender Individuals, QTc Interval | 11/21 | 01/23 | | |
NCT04365764: Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study |
|
|
| Completed | N/A | 400 | Europe | | Groupe Hospitalier Pitie-Salpetriere, Centre Hospitalier Intercommunal Robert Ballanger, Centre Hospitalier Intercommunal Montfermeil-Le Raincy, CMC Ambroise Paré | Covid-19, ARDS, Pneumonia | 12/22 | 12/22 | | |
| Completed | N/A | 1000 | Europe | Any drug used to treat Covid-19 | Groupe Hospitalier Pitie-Salpetriere, CMC Ambroise Paré | Coronavirus, Iatrogenic Disease, Acute Kidney Injury, ARDS, Human | 01/23 | 01/23 | | |
| Recruiting | N/A | 14 | Europe | Collection of mobilized hematopoietic stem cells (apheresis products) from healthy volunteers | Smart Immune SAS | Healthy Volunteers | 08/24 | 08/24 | | |
EXIT, NCT05934214: EXploring Immune-related Adverse Events of Immune checkpoinT Inhibitors Using VigiBase, the WHO Pharmacovigilance Database |
|
|
| Completed | N/A | 141630 | Europe | Immune checkpoint inhibitor | Groupe Hospitalier Pitie-Salpetriere, Institut Curie | Cancer, Immune-related Adverse Event, Immune Checkpoint Inhibitor-Related Myocarditis | 12/23 | 02/24 | | |
DEEPECG4U, NCT05829993: Development of an Artificial Intelligence Algorithm to Detect Pathological Repolarization Disorders on the ECG and the Risk of Ventricular Arrhythmias |
|
|
| Recruiting | N/A | 5000 | Europe | | Assistance Publique - Hôpitaux de Paris, UMMISCO - Institute of Research for Development (IRD), CoreLab Banook | Cardiac Disease, Ventricular Arrythmia | 05/24 | 06/24 | | |
| Recruiting | N/A | 400 | Europe | Monitoring | Groupe Hospitalier Pitie-Salpetriere | Anticoagulants and Thrombotic Disorders | 12/24 | 12/24 | | |
JOCARDITE, NCT04294771: JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors |
|
|
| Recruiting | N/A | 500000 | Europe | ICI, Immune checkpoint inhibitors | Groupe Hospitalier Pitie-Salpetriere | Myocarditis, Cardiomyopathies, Heart Diseases, Cardiovascular Diseases, Pericarditis, Vasculitis | 01/25 | 01/25 | | |
NEOCARDIO, NCT03882580: Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care |
|
|
| Recruiting | N/A | 5000 | Europe | Anti-Cancer Agents | Groupe Hospitalier Pitie-Salpetriere | Cardiovascular Complication, Cardiovascular Insufficiency, Cardiac Complication, Oncologic Complications, Cardiac Insufficiency, Metabolic Disorder, Vascular Disorder, Cardiac Disorder | 03/25 | 03/25 | | |
MASC2, NCT05454527: Follow-up of Patients With Inflammatory Myopathies Associated With a Biobank |
|
|
| Recruiting | N/A | 4000 | Europe | | Assistance Publique - Hôpitaux de Paris | Inflammatory Myositis, Idiopathic Inflammatory Myositis, Drug-induced Inflammatory Myositis | 10/57 | 10/57 | | |
